Feedback?

Based on public information; not affiliated with or endorsed by Pfizer Inc.

Pfizer Inc.: public pathways for academic researchers

Checked 30 Oct 2026.

What Pfizer states on its own public pages about process chemistry, crystallization, continuous manufacturing, solid state, impurities, PAT/digital and sustainable processes; named academic programmes; consortium memberships in our directory; calls on this site; and entry points. Every point cites its source. Checked 30 Oct 2026.

Playbooks: Pitching precompetitive work · Published examples

Themes: Particle engineering · PAT and process modelling (incl. AI/ML-assisted process development) · Biocatalysis · Green and sustainable process · Continuous manufacturing

1. What Pfizer says publicly

These are the areas Pfizer's partnering page lists under "Small Molecule Product & Process Development", where it says it is "looking to partner with others".

Process chemistry

  • Under "Innovative Chemical Synthesis", Pfizer lists synthesis platforms that emphasise sustainability and "green" chemistry, including catalytic methods for building blocks and APIs with stereocenters, earth-abundant alternatives to endangered metals, biocatalysis, and automation and robotics for reaction optimisation.[1]
  • Under "Computational Product and Process Design", Pfizer lists in silico design and screening of synthetic pathways and structure-based stability prediction.[1]

Crystallization

  • Under "Materials Sciences and Particle Engineering", Pfizer lists molecular structure-based particle design and engineering tools for predicting and manipulating crystal form/morphology, solid-state stability and material properties.[1]

Continuous manufacturing

  • Under "Pfizer's Continuous Manufacturing Module", Pfizer describes small-footprint, plug-and-play (modular, continuous) processing platforms for drug product and API that let the same equipment be used for development and commercial manufacturing.[1]

Solid state

  • The same "Materials Sciences and Particle Engineering" area names solid-state stability and material properties.[1]

PAT / digital

  • Pfizer lists advanced process analytical technologies (PAT), sensor integration and microfluidic sample handling compatible with continuous manufacturing, inline real-time analytics that reduce offline testing, and predictive modeling (first-principles and data-driven).[1]

Sustainable process

  • The "Innovative Chemical Synthesis" area is described as emphasising sustainability and "green" chemistry (see above).[1]

Not published by the company on the pages we checked: Impurities (checked 30 Oct 2026).

2. Named academic programmes

Pfizer competitive grants (posted RFPs)

  • Pfizer's competitive grant programme uses a publicly posted Request for Proposal (RFP) that sets out a specific area of interest and timelines; organisations apply to address the gaps described in that RFP.[4]
  • The RFPs listed on the page on 30 Oct 2026 were in clinical research, quality improvement and education topics (for example vaccines, oncology, inflammation and immunology).[4]

The partnering page lists "academic alliances" among Pfizer's partnership models; a named academic programme in process chemistry or manufacturing is not publicly stated on the pages we checked.[1]

3. Memberships in our industry directory

4. Open or recurring calls on this site

No open or recurring Pfizer calls in process chemistry or manufacturing are on this site right now.

5. Entry points

What the labels mean
  • Open to applyA funding programme that eligible researchers can apply to, through the route the official page describes.
  • Needs an internal contactA proposal has to start with, or be sponsored by, someone inside the company.
  • Via a consortium or centerEngagement runs through a consortium or centre that names the company; see its card on /industry/.
  • Members onlyOnly paying or member organisations take part.
  • Partnering enquiry (not a funding call)A route to contact the company about a collaboration; it is not a funding programme.
  • Open to applyPfizer competitive grants: Apply to a posted RFP while it is open; the topics are set in each RFP.[4]
  • Partnering enquiry (not a funding call)Partnering enquiries: The partnering page invites innovators to connect with Pfizer's team about the listed areas.[1]
  • Via a consortium or centerConsortia and centres that name Pfizer: See the memberships above; how outsiders take part differs by centre.[memberships]

6. Sources

  1. Research and Business Development Partnerships (pfizer.com), area: Small Molecule Product & Process Development · https://www.pfizer.com/about/partners/research-and-business-development-partnerships · checked 30 Oct 2026 (by hand; the site does not allow automated checks)
  2. CMAC Medicines Manufacturing Consortium Welcomes Pfizer as Newest Partner (press release, 18 Dec 2017) · https://www.pfizer.com/news/press-release/press-release-detail/cmac-medicines-manufacturing-consortium-welcomes-pfizer · checked 30 Oct 2026 (by hand; the site does not allow automated checks)
  3. NIIMBL membership page (combined member list) · https://www.niimbl.org/membership/ · checked 30 Oct 2026
  4. Competitive Grants (pfizer.com) · https://www.pfizer.com/about/programs-policies/grants/competitive-grants · checked 30 Oct 2026 (by hand; the site does not allow automated checks)
  5. Enabling Technologies Consortium (ETC): ETC Members · https://etconsortium.org/about-us/ · checked 30 Oct 2026
  6. Medicines Manufacturing Innovation Centre (CPI): Industry partners as announced Nov 2022 (CPI's opening announcement, 30 Nov 2022; no current list is published) · https://www.uk-cpi.com/news/cpi-opens-world-leading-medicines-manufacturing-innovation-centre-in-scotland-to-raise-the-bar-in-pharma-manufacturing · checked 30 Oct 2026

Based on public information; not affiliated with or endorsed by Pfizer Inc. Always confirm on the official page.